Loading clinical trials...
Loading clinical trials...
A Multi-center, Prospective, Randomized, Double-blind Study to Assess the Impact of Sacubitril/Valsartan vs. Enalapril on Daily Physical Activity Using a Wrist Worn Actigraphy Device in Adult Chronic Heart Failure Patients
Conditions
Interventions
LCZ696 (Sacubitril/Valsartan)
Placebo of LCZ696 (Sacubitril/Valsartan)
+2 more
Locations
119
Belgium
Novartis Investigative Site
Edegem, Antwerpen, Belgium
Novartis Investigative Site
Dendermonde, Belgium
Novartis Investigative Site
Geel, Belgium
Novartis Investigative Site
Ghent, Belgium
Novartis Investigative Site
Turnhout, Belgium
Novartis Investigative Site
Pleven, Bulgaria
Start Date
December 20, 2016
Primary Completion Date
April 11, 2018
Completion Date
April 11, 2018
Last Updated
September 2, 2020
NCT06148935
NCT06632483
NCT05093933
NCT06697353
NCT05974189
NCT06363110
Lead Sponsor
Novartis Pharmaceuticals
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions